tiprankstipranks
Trending News
More News >
Elevance Health, Inc. (ELV)
NYSE:ELV
US Market

Elevance Health (ELV) Ratios

Compare
2,878 Followers

Elevance Health Ratios

ELV's free cash flow for Q4 2025 was $0.23. For the 2025 fiscal year, ELV's free cash flow was decreased by $ and operating cash flow was $0.01. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.24 1.24 1.10 0.00 0.00
Quick Ratio
1.24 1.24 1.10 0.00 0.00
Cash Ratio
0.48 0.48 0.43 0.00 0.00
Solvency Ratio
0.09 0.09 0.10 0.11 0.11
Operating Cash Flow Ratio
0.21 0.21 0.30 0.00 0.00
Short-Term Operating Cash Flow Coverage
3.11 3.11 2.68 4.30 4.76
Net Current Asset Value
$ -52.74B$ -52.74B$ -54.12B$ -69.52B$ -66.42B
Leverage Ratios
Debt-to-Assets Ratio
0.27 0.27 0.28 0.23 0.23
Debt-to-Equity Ratio
0.76 0.76 0.79 0.64 0.67
Debt-to-Capital Ratio
0.43 0.43 0.44 0.39 0.40
Long-Term Debt-to-Capital Ratio
0.42 0.42 0.42 0.37 0.38
Financial Leverage Ratio
2.77 2.77 2.83 2.77 2.84
Debt Service Coverage Ratio
3.09 3.09 2.55 3.02 3.22
Interest Coverage Ratio
5.79 5.79 7.50 7.49 8.93
Debt to Market Cap
0.51 0.42 0.37 0.23 0.20
Interest Debt Per Share
156.16 156.16 145.52 112.20 104.02
Net Debt to EBITDA
2.46 2.46 2.33 1.77 1.65
Profitability Margins
Gross Profit Margin
25.56%25.56%27.85%100.00%100.00%
EBIT Margin
4.07%4.07%5.14%5.10%5.40%
EBITDA Margin
4.85%4.85%5.93%6.12%6.47%
Operating Profit Margin
4.07%4.07%5.03%4.50%4.85%
Pretax Profit Margin
3.37%3.37%4.47%4.50%4.85%
Net Profit Margin
2.84%2.84%3.38%3.49%3.76%
Continuous Operations Profit Margin
2.84%2.84%3.38%3.50%3.76%
Net Income Per EBT
84.38%84.38%75.66%77.60%77.55%
EBT Per EBIT
82.72%82.72%88.93%100.00%100.00%
Return on Assets (ROA)
4.66%4.66%5.12%5.50%5.74%
Return on Equity (ROE)
13.01%12.90%14.47%15.23%16.26%
Return on Capital Employed (ROCE)
7.99%7.99%9.12%7.08%7.40%
Return on Invested Capital (ROIC)
6.65%6.65%6.74%319.69%333.60%
Return on Tangible Assets
6.91%6.91%7.82%8.16%8.66%
Earnings Yield
8.77%7.28%6.96%5.45%4.79%
Efficiency Ratios
Receivables Turnover
13.07 13.07 13.54 9.59 9.76
Payables Turnover
8.68 8.68 8.10 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
38.81 38.81 33.88 39.31 36.28
Asset Turnover
1.64 1.64 1.51 1.57 1.52
Working Capital Turnover Ratio
39.58 59.52 260.59 0.00 0.00
Cash Conversion Cycle
-14.14 -14.14 -18.10 38.06 37.40
Days of Sales Outstanding
27.93 27.93 26.95 38.06 37.40
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
42.07 42.07 45.05 0.00 0.00
Operating Cycle
27.93 27.93 26.95 38.06 37.40
Cash Flow Ratios
Operating Cash Flow Per Share
19.34 19.34 24.94 34.59 35.00
Free Cash Flow Per Share
14.31 14.31 19.55 29.03 30.20
CapEx Per Share
5.03 5.03 5.39 5.56 4.80
Free Cash Flow to Operating Cash Flow
0.74 0.74 0.78 0.84 0.86
Dividend Paid and CapEx Coverage Ratio
1.62 1.62 2.10 3.00 3.53
Capital Expenditure Coverage Ratio
3.84 3.84 4.62 6.22 7.29
Operating Cash Flow Coverage Ratio
0.13 0.13 0.18 0.32 0.35
Operating Cash Flow to Sales Ratio
0.02 0.02 0.03 0.05 0.05
Free Cash Flow Yield
4.94%4.08%5.30%6.16%5.89%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
11.41 13.73 14.37 18.36 20.89
Price-to-Sales (P/S) Ratio
0.32 0.39 0.49 0.64 0.79
Price-to-Book (P/B) Ratio
1.47 1.77 2.08 2.80 3.40
Price-to-Free Cash Flow (P/FCF) Ratio
20.25 24.50 18.87 16.25 16.99
Price-to-Operating Cash Flow Ratio
15.05 18.12 14.79 13.63 14.66
Price-to-Earnings Growth (PEG) Ratio
4.44 -5.63 8.48 5.50 -7.64
Price-to-Fair Value
1.47 1.77 2.08 2.80 3.40
Enterprise Value Multiple
9.11 10.51 10.52 12.25 13.81
Enterprise Value
88.00B 101.50B 110.32B 128.50B 139.84B
EV to EBITDA
9.11 10.51 10.52 12.25 13.81
EV to Sales
0.44 0.51 0.62 0.75 0.89
EV to Free Cash Flow
27.73 31.98 24.23 18.99 19.30
EV to Operating Cash Flow
20.51 23.66 18.99 15.94 16.65
Tangible Book Value Per Share
20.21 20.21 4.53 16.37 6.80
Shareholders’ Equity Per Share
197.84 197.84 177.42 168.64 151.01
Tax and Other Ratios
Effective Tax Rate
0.16 0.16 0.24 0.22 0.23
Revenue Per Share
897.77 897.77 759.28 735.14 652.48
Net Income Per Share
25.53 25.53 25.68 25.69 24.56
Tax Burden
0.84 0.84 0.76 0.78 0.78
Interest Burden
0.83 0.83 0.87 0.88 0.90
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
0.76 0.76 0.97 1.35 1.40
Currency in USD